IC
LLY icon

Iconiq Capital’s Eli Lilly LLY Stock Holding History

Iconiq Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-357
Closed -$272K – 92
2025
Q3 		$272K Sell
357
-3,349
-90% -$2.49M ﹤0.01% 88
2025
Q2 		$2.89M Sell
3,706
-181
-5% -$141K 0.05% 52
2025
Q1 		$3.21M Buy
3,887
+430
+12% +$358K 0.06% 50
2024
Q4 		$2.67M Buy
3,457
+1,672
+94% +$1.38M 0.04% 54
2024
Q3 		$1.58M Buy
1,785
+1,292
+262% +$1.16M 0.03% 55
2024
Q2 		$446K Buy
+493
New +$394K 0.01% 63

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Iconiq Capital's LLY Position: Q4 2025 in Review

Iconiq Capital sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 357 shares — an estimated $272K sold.

Iconiq Capital first reported a position in LLY in Q2 2024 and held it in 6 quarters. The position peaked at $3.21M in Q1 2025. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Iconiq Capital reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • Iconiq Capital sold 357 Eli Lilly shares in Q4 2025, an estimated $272K.
  • Iconiq Capital first reported a position in Eli Lilly in Q2 2024 and held it in 6 quarters.
  • Iconiq Capital's Eli Lilly position peaked at $3.21M in Q1 2025.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Iconiq Capital's 13F filing for Q4 2025, filed 13 Feb 2026.